Tags : mometasone furoate

Hikma Signs an Exclusive License Agreement with Glenmark to Commercialize

Shots: Glenmark to receive up front, regulatory & commercial milestones along with royalties on sales of Ryaltris in the licensed territory. Glenmark will continue the development of the therapy and is responsible for the US FDA approval Following the approval, Hikma will commercialize the therapy in the US. The focus of the collaboration is to […]Read More